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Background. We initiated differentiation of human embryonic stem cells (hESCs) into dopamine neurons, obtained a purified
population of neuronal precursor cells by cell sorting, and determined patterns of gene transcription. Methodology.
Dopaminergic differentiation of hESCs was initiated by culturing hESCs with a feeder layer of PA6 cells. Differentiating cells
were then sorted to obtain a pure population of PSA-NCAM-expressing neuronal precursors, which were then analyzed for
gene expression using Massive Parallel Signature Sequencing (MPSS). Individual genes as well as regions of the genome which
were activated were determined. Principal Findings. A number of genes known to be involved in the specification of
dopaminergic neurons, including MSX1, CDKN1C, Pitx1 and Pitx2, as well as several novel genes not previously associated with
dopaminergic differentiation, were expressed. Notably, we found that a specific region of the genome located on chromosome
11p15.5 was highly activated. This region contains several genes which have previously been associated with the function of
dopaminergic neurons, including the gene for tyrosine hydroxylase (TH), the rate-limiting enzyme in catecholamine
biosynthesis, IGF2, and CDKN1C, which cooperates with Nurr1 in directing the differentiation of dopaminergic neurons. Other
genes in this region not previously recognized as being involved in the functions of dopaminergic neurons were also activated,
including H19, TSSC4, and HBG2. IGF2 and CDKN1C were also found to be highly expressed in mature human TH-positive
dopamine neurons isolated from human brain samples by laser capture. Conclusions. The present data suggest that the H19-
IGF2 imprinting region on chromosome 11p15.5 is involved in the process through which undifferentiated cells are specified to
become neuronal precursors and/or dopaminergic neurons.
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Activation of Chromosome 11p15.5 and Comparison to Human Dopaminergic Neurons. PLoS ONE 3(1): e1422. doi:10.1371/journal.pone.0001422
INTRODUCTION
The potential value of human embryonic stem cells (hESCs) lies in
their ability to, in theory, generate any type of human cell which
might be useful either for basic research or for direct therapeutic
applications such as transplantation. Methods to differentiate
hESCs into multiple phenotypes including endoderm, mesoderm,
and ectoderm, as well as trophoblast and germ cells, have been
reported [1–4]. Of the many cell types that can be generated from
hESCs, dopaminergic neurons of the midbrain are among the
most interesting. A number of reports have described the
generation of dopamine neurons from animal embryonic stem
cells [5–9]. Dopaminergic neurons can also be generated from
human embryonic stem cells, in most cases employing methods
which involve co-culture with stromal cell lines such as PA6 [9–
12].
Polysialyated neural cell adhesion molecule (PSA-NCAM) has
been found to label a population of cells in the developing spinal
cord, which are distinct from multipotent neuroepithelial cells and
glial progenitors, and are identified as being neuronal-restricted
precursor cells. These cells have the ability to develop into multiple
subtypes of neurons, but generally not glia [13]. PSA-NCAM is
widely used as a marker for neuronal precursors in both
developing and the adult brain [14,15]. It should, however, also
be noted that at least under some circumstances a minority of
PSA-NCAM positive precursor cells differentiate into astrocytes
[16]. PSA-NCAM is expressed in human embryonic stem cells
which are undergoing differentiation to dopaminergic neurons, at
a stage prior to the expression of specific dopaminergic markers
[17]. In Ntera2 human embryonal carcinoma cells undergoing
dopaminergic differentiation, PSA-NCAM
+ cells sorted by flow
cytometry were found to differentiate into functional dopaminer-
gic neurons [18]. Therefore, PSA-NCAM appears to label
dopaminergic neuronal precursors developing from hESCs, in
addition to other possible neuronal subtypes present in differen-
tiating hESCs.
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PLoS ONE | www.plosone.org 1 January 2008 | Issue 1 | e1422The purpose of the present study was to obtain a transcriptional
profile of PSA-NCAM
+ neuronal precursors derived from hESCs,
which we believe includes dopaminergic neuronal precursors.
Previous surveys of gene expression in developing dopaminergic
neurons have employed, for example, developing brain tissue
[19,20], which includes a number of cell types, or cells from
transgenic animals sorted on the basis of TH promoter activity
[21]. The use of hESCs to obtain differentiating dopaminergic
neurons allows for the possibility of using primary human cells,
sorted to obtain a purified population, at a relatively early
developmental stage. We employed PSA-NCAM as a marker for
sorting differentiating hESCs to obtain a purified population of
precursor cells with the potential to develop the dopaminergic
neuronal phenotype. Using MPSS, which is based on sequencing
of 17-mer and 20-mer tags generated by the restriction enzyme
DpnII, we obtained a profile of genes expressed by developing
human neurons derived from hESCs. Among the activated genes
was a cluster of genes on chromosome 11p15.5, in the H19-IGF2
imprinting center, within which are the TH and IGF2 genes, and
the gene for CDKN1C, or p57Kip1, which cooperates with Nurr1
to induce the dopaminergic phenotype [22].
MATERIALS AND METHODS
hESC culture and dopaminergic differentiation of
hESCs
hESC of the BG03 line (BresaGen Inc., Athens, U. S. A.) were
maintained on inactivated mouse embryonic fibroblast feeder cells
in medium comprised of Dulbecco’s Modified Eagle’s Medium/
Ham’s F12 supplemented with 20% knockout serum replacement,
2 mM non-essential amino acids, 2 mM L-glutamine, 50 mg/ml
Penn-Strep (all from Invitrogen, Carlsbad, U. S. A.), 0.1 mM b-
mercaptoethanol (Chemicon International, Inc., Temecula, U. S.
A.), and 4 ng/ml of basic fibroblast growth factor (Sigma Aldrich,
St. Louis, U. S. A.), as previously described [17,23]. Cultures of
hESCs were checked regularly for karyotype abnormalities. Cells
were passaged by manual dissection every 4–6 days.
Dopaminergic differentiation of BG03 was induced by co-
culture with the mouse stromal cell line PA6 as described
previously [9]. Briefly, BG03 cells were seeded at a density of
approximately 1000 clumps per 3 cm dish on a confluent layer of
PA6 feeder cells in Glasgow Minimum Essential Media (Invitro-
gen) supplemented with 10% knockout serum replacement, 1 mM
pyruvate (Sigma), 0.1 mM nonessential amino acids, and 0.1 mM
b-mercaptoethanol.
Fluorescence-activated cell sorting (FACS) and in
vitro differentiation
Flow cytometry was used to isolate NCAM
+ cells from the mixture
of cells present in BG03 and PA6 co-cultures using single label
sorting. Briefly, differentiating hESC were removed from the PA6
cell layer and dissociated with papain (Worthington Biochemical,
Lakewood, U. S. A.) thoroughly washed with PBS+1 mg/mL
BSA+50 mg/mL penicillin/streptomycin, filtered through a
40 mm nylon mesh cell strainer (BD Biosciences, San Jose, U. S.
A.), and stained with PSA-NCAM (1 ug/million cells, Chemicon
MAB1951) for 45 min in staining medium (PA6 conditioned
medium, 10% FBS, and 50 mg/mL penicillin/streptomycin) at
37uCi n5 %C O 2. Cells were then washed three times with
staining medium and incubated with 488-goat anti mouse IgM
secondary antibody (1 mg/million cells, Invitrogen) for 45 min at
37uCi n5 %C O 2, followed by three washes with PBS+1 mg/ml
BSA. Propidium iodide (1 mg/ml) was added to the cell suspension
to discriminate live and dead cell populations. Cells were then
filtered through a 40 mm nylon mesh cell strainer prior to sorting.
The NCAM
+ cells were sorted through a FACSstar plus cell sorter
(BD Biosciences).
For in vitro differentiation, NCAM
+ sorted cells were plated at
2000–4000 cells/ cm
2 onto fibronectin-coated dishes and grown
in PA6 conditioned medium with a medium change at day 1 and
every two days thereafter. Following sorting, cells were allowed to
differentiate for 2–3 weeks prior to immunostaining and
electrophysiological recording.
Electrophysiological recording
Cells were bathed in PBS consisting of (mM) NaCl 137, KCl, 2.68,
KH2PO4 1.47, Na2HPO4 8.1, MgCl2 0.49, CaCl2 0.90, glucose
5.55, sucrose (for osmotic balance) 25.0, pH=7.4, and were
recorded in whole cell mode using patch clamp micropipettes
containing (mM) KCl 140, MgCl2 2, CaCl2 1, EGTA 11, HEPES
10, MgATP 2, pH 7.2. Pipette resistances were 3–6 MV. Signals,
obtained by a List EPC7 amplifier operating in either current
clamp or voltage clamp mode, were digitized by a DigiData 1200
interface (Axon Instruments, Union City, U. S. A.) under
command of the program pClamp v.6 (Axon Instruments). The
neurotransmitters acetylcholine (100 mM), GABA (100 mM), and
glutamic acid (1 mM, as the monosodium salt) were superfused by
means of a microcapillary tube attached to a U-tube that was
directed toward the cell under investigation and suspended above
it by 200 mm. Cells were voltage clamped at 270 mV and
depolarized in 10 mV steps to search for electrical excitability, and
were voltage clamped at 260 mV when tested by application of
neurotransmitters.
RT-PCR and qPCR analysis
Total RNA was extracted from undifferentiated hESCs or
NCAM
+ cells using RNA STAT-60 (Tel-Test Inc., Friendswood,
U. S. A.) and cDNA was synthesized by using a reverse
transcription kit (RETROscript, Ambion, Austin, U. S. A.). The
PCR primers are listed in Table S1. Real-time qPCR was used to
quantify the levels of mRNA expression for selected genes using
the DNA Engine Opticon Fluorescence Detection System (MJ
Research, Waltham, U. S. A.) with DyNAmo SYBR Green qPCR
kits. The content of selected genes was normalized to 18S-rRNA
and standard curves were generated using 10 to 1000 ng cDNA
per 20 ml reaction volume. All PCR products were checked by
melting curve analysis to exclude the possibility of multiple
products or incorrect product size. PCR analyses were conducted
in triplicate for each sample.
Immunocytochemistry
Immunocytochemistry and staining procedures were as described
previously [24]. Briefly, cells were fixed with 2% paraformalde-
hyde for 30 min, blocked in blocking buffer (5% goat serum, 1%
BSA, 0.1% Triton X-100) for 1 hr followed by incubation with the
primary antibody at 4uC overnight. Appropriately coupled
secondary antibodies (Invitrogen) were used for single and double
labeling. All secondary antibodies were tested for cross reactivity
and non-specific immunoreactivity. The following antibodies were
used: TH (1:1000, AF1997; R & D Systems, Minneapolis, U. S.
A.), NCAM (1:1000, Chemicon MAB1951) and TuJ1 (b-III
tubulin, 1:2000, Sigma T8660). Bis-benzamide (Hoeschst 33342,
Sigma 1:1000) was used to identify nuclei. Images were captured
on either a Zeiss (Thornwood, New York, U. S. A.) or Olympus
(Center Valley, U. S. A.) fluorescence microscope.
MPSS Analysis of NCAM
+ Cells
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About 20 mg of total RNA isolated from NCAM
+ cells derived
from BG03 was analyzed through an Agilent Bioanalyzer (Agilent
Technologies, Santa Clara, U. S. A.), passed quality control tests
and qualified for MPSS analysis. The mRNA was processed
according to the MPSS protocol as outlined previously [25,26]
with some modifications. Briefly, the mRNA was reverse-
transcribed and the cDNA was digested with Dpn II. The cDNA
of the last Dpn II site and the downstream 16 bases were cloned
into a Megaclone vector. The resulting library was amplified and
loaded onto microbeads. About 1.2 million microbeads were
loaded into each flow cell and the signature sequences were
determined by a series of enzymatic reactions as outlined in the
above publications. The abundance for each signature was
converted to transcripts per million (tpm) for the purpose of
comparison between samples. To generate a complete, annotated
human signature database, we extracted all the possible signatures
from the human genome sequence and the human UniGene
sequences. Each virtual signature is ranked and assigned a class,
based on its position and orientation in the original sequence. The
annotation database is established based on the virtual signatures,
their classes and their corresponding genes so that each signature
only has one corresponding annotation. The database was then
used to annotate the data from the experiments.
Analysis of human postmortem brain neurons
Fresh frozen tissue blocks corresponding to the substantia nigra
(SN) from 4 control and 4 Parkinson’s disease patients older that
55 years of age were obtained from the New York Brain Bank at
Columbia University and the Brain Institute of University of
Florida (information on the cases used is shown in Table 1). Fresh
frozen sections containing neuromelanin positive cells were cut
8 mm thick, briefly fixed in 70% EtOH and briefly stained with
Nissl stain for neuronal identification using the HistoGeneHLCM
frozen section staining kit (Molecular Devices, Sunnyvale, U. S. A.)
to avoid RNA degradation. Before initiating microdissection, we
determined RNA integrity by detecting 18S and 28S bands on the
RNA 6000 Nano LabChip (Agilent Technologies) from extracted
total RNA. The rRNA ratios ranged between 0.7–1.3. Approx-
imately 200 neuromelanin positive neurons were microdissected
with a Leica LSMLD instrument. Total RNA was isolated from
the neuronal samples with the Pico-Pure RNA isolation kit
(Arcturus Engineering, Mountain View, U. S. A.). A double-round
amplification procedure was performed with the HS RiboAmp
RNA amplification kit, according to manufacturer’s instructions
(Arcturus Engineering). We assessed the amplified copy RNA
quality with the RNA 6000Nano LabChip (Agilent Technologies)
and its quantity by UV spectrophotometry at 260 nm wavelength.
For cDNA synthesis, 0.5 mg copy RNA or 5 mg total RNA
(human SN total RNA, Ambion) was mixed with 2 ml random
decamer primers (Ambion) and 1 ml of a 10 mM dNTP mix
(Roche Applied Science, Indianapolis, U. S. A.), filled up to a final
volume of 13 ml and incubated for 10 min at 65uC. After cooling
on ice, 7 ml of RT master mix (SuperScript III Reverse
Transcriptase, Invitrogen) were added and cDNA synthesis was
performed at 50uC for 60 min and terminated by incubating for
15 min at 75uC. PCR grade water was added to the reaction
mixture to a final volume of 100 ml. PCR was performed on the
ABIHT7900 instrument (Applied Biosystems [ABI], Foster City,
U. S. A.), using the DNA binding dye SYBR Green I for the
detection of PCR products. PCR reactions were set using 2 ml
cDNA with 18 ml of a SYBR Green I master mix containing
forward and reverse primers (Table S2), MgCl2 and SYBR Green.
A blast search for each primer pair verified that the binding sites
were unique for each gene studied. For detection of TH in the
collected samples, a pre-designed assay-on-Demand
TM Taq-
man
TM probe and primer pair was obtained from ABI
(Mm00447546_m1).
RESULTS
On day 0, undifferentiated BG03 cells were transferred to co-
culture with mouse stromal PA6 cells. TH-positive cells were first
detected in small numbers at days 10–12. Numerous b-III tubulin
(Tuj1)
+ cells and TH
+ cells were identified in the cultures by days
16 and 21, respectively (Fig. 1A–B).
PSA-NCAM was expressed in a typical cell surface pattern in
52% of the hESC colonies at day 10, and the percentage of
positive colonies increased to 75% at day 12 (Fig. 1C). No
significant increase in PSA-NCAM
+ cells was observed between
days 12–18 of differentiation. A high percentage of cells (.50%) in
the majority of colonies (.50%) were positive for NCAM (Fig. 1D).
Based on the time course of NCAM and TH expression during
differentiation, we chose day 14 as the time point for enriching
dopaminergic neuronal precursors by FACS. The yield of PSA-
NCAM
+ cells by FACS was approximately 21% of the total cells.
NCAM
+ cells differentiate into TH
+ neurons in vitro
When FACS-isolated PSA-NCAM
+ cells were placed back into
culture subsequent to sorting, cells resembling neural stem cells
with rosette structures, and cells with a neuron-like bipolar
morphology were present (Fig. 1E).
To evaluate the degree of differentiation in NCAM
+ cells, we
determined the expression of several undifferentiated hESC
markers and dopaminergic/neuronal markers by RT-PCR. No
or very low levels of expression of three undifferentiated markers
(UTF1, DPPA5 and Nanog) was found in PSA-NCAM
+ cells,
whereas Oct4 was detected (Fig. 1F). Expression of four neuronal
markers (TH, Lmx1b, Pitx3 and TrkB) was detected in sorted cells
(Fig. 1F). Numerous TH-positive cells were present after 10 to 20
days of culture in the presence of SHH and FGF8 (Fig. 2A).
Electrophysiological recording from FACS-sorted PSA-NCAM
+
cells that were subsequently differentiated in PA6 conditioned
medium for three weeks showed that these cells were electrically
excitable (Fig. 2B), as evidenced by inward sodium currents
(Fig. 2C) and by the delayed rectifier currents (carried by
potassium) seen as the upward bend in the current-voltage plot
Table 1. Control and Parkinson’s disease case information.
......................................................................
Case Age Sex
PM1
(hours) Cause of Death
Parkinson’s disease cases
1 80 F Unknown Unknown
2 76 M 18 Pneumonia
3 81 F 17 Complication of disorder
4 79 F 14 Unknown
Aged matched control cases
5 82 F 9 Unknown
6 71 M Unknown Cancer
7 77 M 18 Pancreatic cancer
8 80 M 21 CPA
9 86 M Unknown Congestive heart failure
doi:10.1371/journal.pone.0001422.t001
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PLoS ONE | www.plosone.org 3 January 2008 | Issue 1 | e1422(Fig. 2D). Of 44 cells tested, 30 (68%) gave clear sodium currents,
and 32 (73%) displayed the characteristic delayed rectifier curve.
Action potentials were observed in many cells recorded under
current clamp conditions (Fig. 2E). In addition, sensitivity to the
neurotransmitters GABA, glutamate and acetylcholine was tested.
Most cells responded to GABA (20/28 or 71%) and generally gave
very large currents of hundreds of pA (Fig. 2F). A smaller
proportion of cells responded to glutamate (12/29 or 41%) and
acetylcholine (5/27 or 18%), with smaller currents of 100 pA or
less (Fig. 2G–H).
MPSS profiling
The total number of distinct sequences detected by MPSS was
11912. The complete datasets for both 17-nucleotide and 20-
nucleotide signatures are available for download from ftp://137.
187.144.38/freed. The distribution frequency of these signatures is
shown in Table 2, with the signature distribution in undifferen-
tiated hESCs shown for comparison. The transcriptional com-
plexity of hESC-derived NCAM
+ cells (11912 total signatures) was
substantially less than that of undifferentiated hESCs (38403 total
signatures), but comparable to that seen in hESC-derived EBs [27]
and neural stem cells (unpublished data). Similar to undifferenti-
ated hESCs, most genes were expressed at relatively low levels
with greater than 60% of the genes being expressed at lower than
50 tpm and 25% lower than 10 tpm.
Fewer than 2% of the expressed genes (131 signatures) were
expressed at a level higher than 1000 tpm. Only 8 genes were
expressed at greater than 10,000 tpm, and only two, IGF2 and
H19, were expressed at greater than 50,000 tpm. Most of the
highly abundant genes were ribosomal, mitochondrial and
housekeeping genes, whereas growth factors, transcription factors
and regulators of gene expression were generally expressed at
lower tpm. A list of the 100 most highly expressed genes is shown
in Table 3, which also lists the 100 genes most highly expressed in
undifferentiated hESCs.
Genes uniquely expressed in NCAM
+ cells
Of the 11912 expressed genes detected in NCAM
+ cells, 232 were
either expressed only in NCAM
+ cells but not in undifferentiated
hESCs, or expressed at levels at least 10-fold higher in NCAM
+
cells as compared to undifferentiated hESCs. These included 195
known genes and 37 novel genes. Of the 195 known genes, there
were 66 that encoded signal transduction proteins, 46 ECM
proteins, 37 nuclear proteins, 33 metabolic proteins, 10 structural
proteins, 2 ribosomal proteins and one mitochondrial protein
(Table S3). Notably, several transcription factors associated with
early neural and dopaminergic differentiation were highly
expressed in NCAM
+ cells. For example, Msx1 was found to be
expressed at a very high level (1098 tpm) in NCAM
+ cells but was
absent in undifferentiated hESCs. Other transcription factors that
were highly expressed in NCAM
+ cells included Pitx1 and Pitx2.
We also noted that many genes of the solute carrier family were
expressed at very high levels in NCAM
+ cells (Table 4). In
contrast, several markers characteristic of pluripotency including
Oct4 and Nanog were not detected in NCAM
+ cells.
When the 232 uniquely or highly expressed in NCAM
+ cells were
sorted for chromosomal locations, they were generally distributed
across all chromosomes, with relatively higher numbers of genes on
chromosomes 1, 5, 10, 11, 14, 17, and 19 (Fig. 3A). Examination of
cytogenetic map locations (Table S4)revealed a number of localized
clusters of genes that were highly expressed in NCAM
+ cells; most
notably, five genes located on chromosome 11p15.5, at or near the
H19-IGF2 imprinting center were highly expressed. These were
H19, IGF2, CDKN1C, TSSC4, and HBG2. Representations of
locations and expression levels of genes in this chromosomal region,
from 1.9 to 5.5 MB from the telomere, in NCAM
+ cells as
comparedtoundifferentiated hESCsareshowninFigure3Band3C.
It is clear that several genes in this region are highly expressed in
NCAM
+ sorted cells, but not in undifferentiated hESCs (Fig. 3C).
Among the genes in this region are H19 and IGF2, the only two
genes with expression above 50,000 tpm. Some of the same genes
areexpressedin embryoidbodies and oligodendrocyte precursors as
well, although not at the high levels seen for NCAM
+ sorted cells
(data not shown). There was also a prominent cluster of highly
expressed genes at 14q24.3 (see Table S4).
Remarkably, the gene for TH, a marker of mature dopami-
nergic neurons, and the rate-limiting enzyme in catecholamine
biosynthesis, is located within the 11p15.5 gene cluster, and is
known to be expressed in the sorted cell population (Fig. 1F and
2A). Although TH was not detected in the NCAM
+ cells, this is
likely because TH is not reliably detected by the classic MPSS
protocol where amplification of cDNA between the last Dpn II site
and the polyA tail is required. In rare cases, where there is a long
span of more than 1 kb between the polyA tail and the first DpnII
site, these signatures usually fail to be amplified and are not
detected. TH was also not detected in a MPSS database of 32
Figure 1. Expression of neuronal markers in hESCs during dopami-
nergic differentiation and in FACS-isolated NCAM
+ cells. (A) A culture
of hESCs differentiated for 16 days on PA6 cells immunostained for b-III-
tubulin. (B) Immunostaining for TH after 21 days. Bar=50 mm. (C)
Quantification of hESC colonies positive for PSA-NCAM, during
differentiation of hESCs co-cultured with PA6 cells. (D) Expression of
PSA-NCAM in day 14 hESCs by immunocytochemistry. Bar=50 mm. (E)
Morphology of FACS-isolated hESC by PSA-NCAM after 14 days of
subsequent differentiation. (F) Expression of markers for undifferenti-
ated hESC and neuronal markers in FACS-isolated NCAM
+ cells by RT-
PCR.
doi:10.1371/journal.pone.0001422.g001
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PLoS ONE | www.plosone.org 5 January 2008 | Issue 1 | e1422human tissues which included the adrenal gland ([28]; http://
mpss.licr.org/index.php).
Verification of gene expression
To verify the differential expression in NCAM
+ cells detected by
MPSS, we selected 18 genes (EMP3, SLC7A7, Pitx1, Msx1, Pitx2,
SDF2L1, NPY and NINJ1, Hs.551588 (H19), Hs.19193,
Hs.473109, Hs.109798, Hs.534052, Hs.446315, Hs.211282 and
Hs.479491, TSSC4, and IGF2) for RT-PCR analysis (Fig. 4).
Expression of all genes was detected in NCAM-sorted cells by
RT-PCR, indicating the reliability of MPSS analysis. Of the
known genes, two (SDF2L1 and NINJ1) were also expressed in
undifferentiated cells whereas the other six (EMP3, SLC7A7,
Pitx1, Pitx2, Msx1, and NPY) were absent or only slightly
expressed in undifferentiated hESCs (Fig. 4A).
Among the unknown genes, Hs.446315, Hs.109798, and
Hs.211282 were detected in both NCAM
+ cells and undifferen-
tiated hESCs (Fig. 4B). Hs.534052, Hs.473109, Hs.479491,
Figure 2. FACS-isolated NCAM
+ cells derived from hESCs differentiated into dopaminergic neurons sorted in vitro NCAM
+. Cells were
differentiated in medium conditioned on PA6 cells for 21 days prior to immunocytochemical staining and electrophysiological recording. (A)
Representative TH staining (Calibration bar=100 mm). (B) A representative PSA-NCAM sorted cell. (C–D) The downward deflections are inward
currents mediated by sodium channels. They are followed by the prolonged upward currents, the delayed rectifier, mediated by potassium channels.
(E) Action potentials trigged by a step injection of current in the cell under the current clamp mode of recording. (F–H) Responses to
neurotransmitters GABA (F), Glutamate (G) and acetylcholine (H).
doi:10.1371/journal.pone.0001422.g002
Table 2. TPM distribution in NCAM
+ cells and undifferentiated hESCs.
..................................................................................................................................................
NCAM
+ Undifferentiated hESCs
MPSS (tpm) No. of Signatures Percentage MPSS (tpm) No. of Signatures Percentage
$10,000 8 0.11 $10,000 2 0.02
$5,000 19 0.28 $5,000 16 0.20
$1,000 131 1.92 $1,000 122 1.52
$500 266 3.91 $500 279 3.48
$100 1555 22.84 $100 1621 20.22
$50 2708 39.78 $50 2953 36.83
$10 5088 74.74 $10 6345 79.13
$3 6352 93.30 $3 7761 96.79
$1 6808 100.00 $1 8018 100.00
doi:10.1371/journal.pone.0001422.t002
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Table 3. The 100 most-highly expressed genes (in TPM) for NCAM
+ and undifferentiated BG02 cells.
..................................................................................................................................................
Category Only in NCAM+ Cells Common Genes Only in BG02 Cells
Ribosomal proteins RPL17, RPL7A, RPS18, RPS27, RPS5 (5) PRDX6, RPL10, RPL11, RPL13, RPL13A,
RPL23A, RPL26, RPL28, RPL30, RPL32,
RPL35, RPL37A, RPL4, RPL6, RPL8, RPS15,
RPS15A, RPS17, RPS19, RPS2, RPS20, RPS27A,
RPS28, RPS3, RPS3A, RPS7, RPSA (27)
FAU, RPL12, RPL14, RPL21, RPL22,
RPL27A, RPL5, RPS6, RPS9 (9)
Mitochondrial protein ATP5B (1) ATP5O (1) NDUFS5 (1)
Structural proteins COL18A1, KRT18, KRT19, TPM1 (4) ACTB, CFL1 (2) DMD, MRCL3, PFN1, STMN1, TMSB4X,
VCP (6)
Prime membrane proteins
and ECM proteins
AQP1, CD99, COL1A1, COL1A2, COL3A1,
COL5A1, COL6A3, DCN, FBLN1, FN1,
LUM, SLC2A1 (12)
COL6A1, KRT8 (2) CD24, GJA1, IFITM1 (3)
Metabolic proteins ARF1, EEF2, GPX4, GSTP1, ISYNA1,
OAZ1, P4HB, PLTP, SERPINH1, TPI1,
UBA52, UBB, UPF2 (13)
ALDOA, EEF1A1, FTH1, FTL, GAPD,
PPIA, SDHB, SUI1 (8)
EEF1G, HSPCA, PKM2, PSMA7, SSB,
UCHL1, UGP2 (7)
Signal transduction
proteins
BST2, CCNI, CDKN1C, FRZB, IGF2,
MAGED2, NGFRAP1, S100A10, SPARC (9)
GNAS, HSPCB, MIF, SERF2, TMSB10,
TPT1 (6)
DCOHM, GDI2, GNB2L1, HSPE1,
YWHAQ, YWHAE (6)
Nuclear proteins HAND1, JUND, NSEP1, PITX1 (4) H3F3A (1) CLU, DNMT3B, G22P1, HMGA1,
HNRPA1, IGAAD, LIN28, NACA, NASP,
NCL, NPM1, NSEP1, POU5F1, PTBP1,
PAI-RBP1, SET, TERF1, XRCC5 (18)
Unknown genes C20orf149, LOC92154, MGC5178, NME4,
syntaxin 7 (5)
Hs.461412, Hs.476965, Hs.571693 (3)
Total Number: 53 47 53
doi:10.1371/journal.pone.0001422.t003
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PLoS ONE | www.plosone.org 6 January 2008 | Issue 1 | e1422Hs.19193 and Hs.551588 (H19) were undetectable or only weakly
expressed in undifferentiated hESCs, but strongly expressed in
NCAM-sorted cells. These differentially-expressed genes might be
further explored as markers for the dopaminergic phenotype.
We selected 2 genes (Pitx1 and SDF2L1) for qPCR analysis. As
shown in Figure 4B, Pitx1 and SDF2L1 were expressed at 6.6-fold
and 1.8-fold higher in NCAM
+ cells than in undifferentiated
hESCs, respectively.
Three genes in the 11p15.5 region were selected for RT-PCR
analysis. Hs.551588 (H19, Fig. 4B) and IGF2 were expressed in
NCAM
+ sorted cells, but not undifferentiated hESCs (Fig 4D).
TSSC4 was expressed in undifferentiated hESCs as well.
Expression of IGF2 and TSSC4 was also detected in unsorted
12-day differentiated hESCs (Fig. 4D).
Expression of H19, IGF2, and CDKN1C in human
dopaminergic neurons
We also examined expression of H19, IGF2, and CDKN1C in
laser-captured dopamine neurons, identified on the basis of
neuromelanin presence, from a series of human postmortem
RNA samples from human cases of Parkinson’s disease and
controls (see Table 1). TH was amplified from each of the samples,
verifying that the collected neurons were dopaminergic (Fig. 5A).
H19 was found to be expressed in the midbrain, but was not
expressed in dopamine neurons per se. CDKN1C was expressed
in all samples of laser-captured dopamine neurons (Fig. 5B). These
samples were probed for two IGF2 transcripts, and one was
positive (NM_001007139), while BC000531 was negative (Fig. 5B).
Therefore, certain genes within the H19 cluster, including TH,
CDKN1C, and one IGF2 transcript are expressed in mature
human dopamine neurons in vivo.
DISCUSSION
The chromosomal region 11p15.5 has been extensively studied,
largely because of it’s properties as an imprinting center [29–31].
This region contains a number of genes which are imprinted, that
is, expressed only from either the paternal or maternal allele, as
well as several other non-imprinted genes [32–34]. In addition to
the two widely-studied imprinted genes, H19 which is maternally
Figure 3. Chromosomal distribution of genes in NCAM
+ sorted cells mapped to chromosomes. (A) Plot of percentages of total detected genes
expressed on each chromosome. (B) Representation of the locations of the highly-expressed genes in 11p15.5, as described in the text. (C) Expression
levels (tpm) for genes in the 11p15.5 region in NCAM
+ neuronal precursor cells as compared to undifferentiated hESCs.
doi:10.1371/journal.pone.0001422.g003
Table 4. Genes of the solute carrier family which were highly expressed in NCAM
+ cells.
..................................................................................................................................................
Accession Symbol Description NCAM+ BG02
Hs.473721 SLC2A1 Solute carrier family 2 (facilitated glucose transporter), member 1 2592 101
Hs.529285 SLC40A1 Solute carrier family 40 (iron-regulated transporter), member 1 498 0
Hs.513147 SLC7A7 Solute carrier family 7 (cationic amino acid transporter, y+ system), member 7 264 0
Hs.396783 SLC9A3R1 Solute carrier family 9 (sodium/hydrogen exchanger), member 3 regulator 1 210 0
Hs.403790 SLC25A28 Solute carrier family 25, member 28 200 0
Hs.521934 SLC39A4 Solute carrier family 39 (zinc transporter), member 4 183 0
Hs.500761 SLC16A3 Solute carrier family 16 (monocarboxylic acid transporters), member 3 176 0
Hs.363138 SLC27A1 Solute carrier family 27 (fatty acid transporter), member 1 150 0
doi:10.1371/journal.pone.0001422.t004
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PLoS ONE | www.plosone.org 7 January 2008 | Issue 1 | e1422imprinted and codes for an un-translated RNA, and the IGF2
gene, which is imprinted paternally, this region contains at least
ten other imprinted genes [29]. H19 and IGF2 are expressed in
various tissues during development and down-regulated in most
mature tissues [35]. H19 expression can be up-regulated in
tumors, but is also expressed in certain normal mature tissues,
notably adrenal gland, muscle, heart, thyroid, mammary gland,
skin, and esophagus; nonetheless, the function of H19 remains
unclear [36]. The IGF2 gene, in contrast, has a number of
transcripts, including an insulin-IGF2 read-through transcript and
an antisense transcript [37], some of which are widely expressed in
mature tissues.
Although the H19 region has been studied mainly in association
with imprinting, it appears that this region contains a precisely-
structured cluster of genes which evolutionarily precedes imprint-
ing. An almost identical gene grouping is present in the chicken
[38], where no imprinting occurs. Also, a paralagous grouping of
genes is present on chromosome 12, apparently haven arisen
through gene duplication and subsequent tetraploidy [39]. A
similar imprinting center, which contains an almost identical
grouping of genes but with major differences in both imprinting
and deletion of large repetitive sequences, occurs on chromosome
7 of the mouse [32]. The mouse H19-IGF2 region on
chromosome 7 also regulates expression of genes on mouse
chromosome 11 via CCCTC-binding factor [40]. In addition, the
11p15.5 region influences gene expression on chromosome 17, in
an area which contains a number of genes related to neuronal
function, including NF1 [41], the dopamine D3 receptor [42], and
mSWiP-2 or WSB-1, a SHH interacting protein [43,44].
Therefore, it seems probable that the H19-IGF2 imprinting
center contains a clustering of genes which is of fundamental
biological importance, beyond their association for the purpose of
imprinting. In fact, it might be conjectured that imprinting arose
subsequent to evolution of the cluster, as a mechanism to control
levels of gene expression in a region of major developmental
significance. Through many lines of evidence, it has been
recognized that genes in this region are important for development
[e.g., 45–47].
Figure 4. Verification of genes uniquely expressed in NCAM
+ cells by RT-PCR and qPCR. Eighteen genes that were highly expressed in NCAM
+ cells
were selected for verification by RT-PCR. (A) Expression of EMP3, SLC7A7, Pitx1, Msx1, Pitx2, SDF2L1, NPY and NINJ1 was detected in NCAM
+ cells by
RT-PCR. Of these, two (SDF2L1 and NINJ1) were also expressed in undifferentiated cells, and the other 6 genes (EMP3, SLC7A7, Pitx1, Pitx2, Msx1 and
NPY) were expressed only in NCAM
+ cells but were absent or expressed at very low levels in undifferentiated hESCs. (B) qPCR results for Pitx1 and
Sdf2l1 expression in NCAM
+ cells and undifferentiated hESCs. (C) Expression of seven unknown genes lacking known protein products in
undifferentiated hESCs and in NCAM
+ sorted cells. Hs.534052, Hs.473109, Hs.479491, Hs.19193 and Hs.551588 (H19) were detected only in NCAM
+
sorted cells. Hs.446315 was detected in undifferentiated hESC, but at a lower level than for NCAM
+ sorted cells. No difference in expression was
detected for Hs.109798 or Hs.211282. (D) RT-PCR examination of IGF2 and TSSC4 expression in undifferentiated hESCs and NCAM
+ sorted cells IGF2
and TSSC4 were also examined in 12-day differentiated, unsorted cultures (Diff D12). IGF2 was not detected in the undifferentiated hESCs, whereas no
difference was seen for TSSC4.
doi:10.1371/journal.pone.0001422.g004
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PLoS ONE | www.plosone.org 8 January 2008 | Issue 1 | e1422Figure 5. Expression of H19, CDKNIC and 1GF1 in mature human dopaminergic neurons. (A) Amplification plot for tyrosine hydroxylase copy RNA
from neuromelanin-positive cells collected by laser capture microdissection in 4 control and 4 Parkinson disease cases (samples 1–8 in Fig. 2). For all
samples analyzed, a sequence specific for tyrosine hydroxylase (Ct 22-32) was amplified, indicating the selection of dopaminergic cells. (B) Imageso f
ethidium bromide gels showing the PCR products amplified from reversed-transcribed RNA extracted from the substantia nigra. Lines 1–8 correspond
to amplified copy RNA from neuromelanin (+) neurons collected by laser capture microdissection from Parkinson’s disease patients (1–4) and age-
matched controls (5–8). Line 9 corresponds to total RNA isolated from the substantia nigra of an age-matched control. DNA size markers (1 kb plus
ladder, Life tech) are shown on left and right.
doi:10.1371/journal.pone.0001422.g005
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PLoS ONE | www.plosone.org 9 January 2008 | Issue 1 | e1422Despite the extensive attention which has been paid to this gene
cluster, no specific biological process which might be related to this
grouping of genes has been identified. It has recently been
reported that H19 is a microRNA precursor, and may regulate
development by that means [48]. It is perhaps noteworthy that this
region contains two genes which are of central importance to
major endocrine and secretory functions, the insulin gene and the
TH gene, encoding the rate-limiting enzyme in catecholamine
synthesis. TH is crucial for the synthesis of norephinephine and
epinephrine, which are produced mainly in the adrenal medulla.
In addition, the TH enzyme is rate-limiting for catecholamine
synthesis in central norephinephrine and dopamine-producing
neurons; dopaminergic neurons are present and play important
roles in the control of motor function in virtually all animal species
[e.g., 49].
The occurrence of these two genes within the H19-IGF2
imprinting center is suggestive, yet there is no apparent reason for
their proximity or grouping within other genes in this region. It is
noteworthy, however, that imprinting of genes in this region
appears to have a role in the regulation of insulin secretion
[50,51]. H19 and IGF2 are expressed in the adult pancreas [52].
The present data suggest that the H19-IGF2 region may be
involved in dopamine neuron specification as well.
It is recognized that clusters of co-expressed genes are
distributed throughout the genome [53]. In hESCs and EBs,
regions of chromosomal co-expression have been identified,
including an area near the telomere of chromosome 11p [54]
which would include H19 and IGF2. Expression of H19 and IGF2
is generally high during embryogenesis, but in mature tissues H19
shows a very restricted expression. De-differentiation, as occurs in
tumor cells, generally results in a re-expression of H19 in various
cell types [47]. Although H19 and IGF2 are expressed in the adult
pancreas [52], there is not a simple association between H19 and
IGF2 expression with the expression of TH or insulin. In the
developing adrenal gland, H19 is strongly expressed in the cortex,
while IGF2 is highly expressed in the fetal zone. The fetal zone
contains the precursors of chromaffin cells, which later aggregate
and give rise to the medulla, where high levels of TH are
expressed. Interestingly, in an MPSS study of gene expression in
adult mouse tissues, the adult adrenal gland had high levels of
expression of TH (2472 tpm), and even higher expression of CD81
(3701 tpm) and CDKN1C (4070 tpm), while H19 and IGF2 were
expressed at relatively low levels (164 and 23 tpm respectively;
mouse Reference Transcriptome Database (MRTD), http://www.
ncbi.nlm.nih.gov/projects/geo/info/mouse-trans.html).
Dopaminergic neurons perform a wide range of functions
related to their ability to form and maintain connections with
other neurons, interact with other cells, process and release
neurotransmitter, and adapt to environmental signals and stressors
[55–58]. Understanding the unique features of dopaminergic
neurons is likely to be important for enabling the design of
therapeutic and neuroprotective strategies, as well as to manipu-
late their function for the purpose of targeting human disorders.
The process by which midbrain dopaminergic differentiation
initiated in mice is reasonably well understood. Glia-like floor plate
cells are converted to dopaminergic neurons through the actions of
SHH and FGF8. SHH regulates the expression of a series of
homeodomain transcription factors including MSX1 and Lmx1a,
which initiate the specification of the dopaminergic neuronal
phenotype [59]. Subsequent differentiation is controlled by
additional transcription factors, especially Nurr1, Lmx1b, En1,
Pitx3, and Ngn2 [8,60,61]. Nurr1 cooperates with CDKN1c, or
p57Kip1, to induce the dopaminergic phenotype [22].
The mature phenotype of dopaminergic neurons is known to
involve a number of features related to neurotransmitter
production and release, as well as a number of less-well understood
properties related to the maintenance of synaptic connections.
Therefore, the process through which the dopamine neuronal
phenotype is initiated, and the final mature functional phenotype
of dopamine neurons have been studied in some detail. The
intermediate steps in the maturation of dopaminergic neurons
involve a complex process, many elements of which are still
unknown.
Overall, in addition to TH, the 11p15.5 region contains a
number of genes which are known to be important in the function
of the brain dopaminergic system, including CDKN1C, the D4
dopamine receptor, and CD81 [62–64]. In addition, the
CDKN1C gene, which is also within the 11p15.5 cluster, is
important for differentiation of dopaminergic neurons [22], in
addition to a more general role in cell cycle exit and cell
differentiation [65].
Despite many studies involving genetic manipulation of the H19
locus and examination of expression patterns, the function of the
H19 gene and the surrounding region remains uncertain. Bendall
and coworkers [66] have recently reported that IGF2 is involved in
maintaining hESC self-renewal and pluripotency. The present
data suggest that the H19-IGF2 imprinting region on chromosome
11p15.5 is involved in regulation of the process through which
undifferentiated cells are specified to become dopaminergic
neuronal precursors.
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